David Koos
Chief Executive Officer bei REGEN BIOPHARMA, INC.
Vermögen: 336 631 $ am 31.03.2024
Aktive Positionen von David Koos
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REGEN BIOPHARMA, INC. | Chief Executive Officer | 24.04.2012 | - |
| Chairman | 24.04.2012 | - | |
| Director of Finance/CFO | - | - | |
| Comptroller/Controller/Auditor | 24.04.2012 | - | |
| President | 29.05.2013 | 30.04.2015 | |
| Corporate Secretary | 24.04.2012 | - | |
| Treasurer | 24.04.2012 | - | |
| BST Partners, Inc. | Chief Executive Officer | 30.11.2018 | - |
| Chairman | 30.11.2018 | - | |
| Kcl Therapeutics, Inc. | Chief Executive Officer | 23.03.2021 | - |
| Chairman | 23.03.2021 | - | |
| President | 23.03.2021 | - | |
| Corporate Secretary | 23.03.2021 | - | |
| Treasurer | 23.03.2021 | - | |
| AFN Trust | Director/Board Member | - | - |
| BMXP Holdings Shareholders Business Trust | Director/Board Member | - | - |
| Cell Source Research, Inc. | Director/Board Member | 24.03.2003 | - |
| Chief Executive Officer | 24.03.2003 | - | |
| President | 24.03.2003 | - | |
| Venture Bridge, Inc. | Chief Executive Officer | 21.11.2001 | - |
| President | 21.11.2001 | - |
Karriereverlauf von David Koos
Ehemalige bekannte Positionen von David Koos
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYBLEU INC. | Chief Executive Officer | 12.06.2020 | 13.12.2022 |
| Chairman | 12.06.2020 | 13.12.2022 | |
| Director of Finance/CFO | 12.06.2020 | 21.07.2020 | |
| President | 12.06.2020 | 13.12.2022 | |
| Corporate Secretary | 12.06.2020 | 13.12.2022 | |
| Treasurer | 12.06.2020 | 13.12.2022 | |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Chief Executive Officer | 18.06.2015 | 22.01.2020 |
| Chairman | 18.06.2015 | 22.01.2020 | |
| Director of Finance/CFO | 18.06.2015 | 01.02.2017 | |
| President | 18.06.2015 | 01.02.2017 | |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░░ | - | - |
Ausbildung von David Koos
| University of California, Riverside | Graduate Degree |
| Atlantic International University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 22 |
| China | 2 |
Operativ
| President | 15 |
| Chairman | 14 |
| Chief Executive Officer | 11 |
Sektoral
| Health Technology | 7 |
| Finance | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| REGEN BIOPHARMA, INC. | Health Technology |
| RIVULET MEDIA, INC. | Technology Services |
| ENTEST GROUP, INC. | Finance |
| SYBLEU INC. | Commercial Services |
| Private Unternehmen | 16 |
|---|---|
Cell Bio-Systems, Inc.
 Cell Bio-Systems, Inc. Medical SpecialtiesHealth Technology Cell Bio-Systems, Inc. developed medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries. The company was headquartered in San Diego, CA. | Health Technology |
| Tasco Holdings International, Inc. | Finance |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
| BMXP Holdings Shareholders Business Trust | |
JB Clothing Corp.
 JB Clothing Corp. Apparel/Footwear RetailRetail Trade JB Clothing Corp. designs and manufactures women's fashion apparels. It manufactures and markets shorts, tops, Tees, and hats. It was founded on September 24, 2008 and is headquartered in Las Vegas, NV. | Retail Trade |
Freedom Environmental Services, Inc.
 Freedom Environmental Services, Inc. Miscellaneous Commercial ServicesCommercial Services Freedom Environmental Services, Inc. provided waste water and storm-water system management, grease and organics collection and disposition, and commercial plumbing and water system management to the commercial and industrial customers. The company was founded on October 6, 1978 and is headquartered in Orlando, FL. | Commercial Services |
| BEFUT International Co. Ltd. /Old/ | Producer Manufacturing |
| Entest BioMedical, Inc. /Old/ | Health Technology |
| Venture Bridge, Inc. | |
| Cell Source Research, Inc. | |
| AFN Trust | |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Health Technology |
| Kcl Therapeutics, Inc. | |
| BST Partners, Inc. | |
| BST Partners, Inc. (Wyoming) | |
| BMXP Holdings, Inc. | Health Technology |
- Börse
- Insiders
- David Koos
- Erfahrung
